iMS

simLa® 6 Venous laser clearly ahead Undisputed: Endovenous laser therapy is superior to the open procedure (“stripping”) in many respects. Simpler to manage and also more pleasant for patients due to its lower potential risk, this outpatient laser procedure is a more cost-effective and gentler option for treating varicose veins. Amongst laser procedures themselves, the minimally-invasive treatment of varicosis using simLa®6 is one of the gentlest and most advanced systems and is considered one of the best in its class. Please peak in into our flyer to get to know more about simLa® 6 #surgery #nohospital #varicoseveins #varicoseveintreatment #simLa6 #VenousLaser #iMS

𝗜𝘁'𝘀 𝗮𝘀𝘁𝗼𝗻𝗶𝘀𝗵𝗶𝗻𝗴! Whenever I ask someone which company was the first to bring a 1940nm diode laser for EVLA onto the market, no one would have expected it from iMS. Thereby it's often small, innovative companies that invent new solutions and even dare to go to the market.

𝗗𝗶𝗱 𝘆𝗼𝘂 𝗸𝗻𝗼𝘄, 𝘁𝗵𝗮𝘁 𝗶𝗠𝗦 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝘄𝗮𝘀 𝘁𝗵𝗲 𝗳𝗶𝗿𝘀𝘁 𝗰𝗼𝗺𝗽𝗮𝗻𝘆 𝘄𝗼𝗿𝗹𝗱𝘄𝗶𝗱𝗲 𝘁𝗵𝗮𝘁 𝗹𝗮𝘂𝗻𝗰𝗵𝗲𝗱 𝗮 𝟭𝟵𝟰𝟬𝗻𝗺 𝗱𝗶𝗼𝗱𝗲 𝗹𝗮𝘀𝗲𝗿? It was beginning of 2019 when iMS introduced simLa® 6, the first diode laser of 1940nm wavelength worldwide which led to a patent in more than 20 countries. Before this, lasers with 1940nm were built in small numbers and different techniques – larger, heavier and more complicated. Not suitable for commercial use. However, these devices can be seen as the predecessors of simLa® 6. In 2016, Dr. Michael Schubert - the founder of iMS Medical - got the idea to construct a simpler kind of laser, more compact, less complicated and affordable for actually every professional. Before this he spent many years in other companies investigating in the technique of 1940nm laser. When he started iMS one of the main complications were that main components of the construction kit were not available at that time like nowadays. As an expert in laser technology, Dr. Schubert found a way to develop and manufacture a diode laser module of compact size.  That was the birth of simLa® 6, the first diode laser of 1940nm with its reliable, cost efficient and precise technique.

𝟲𝟲. 𝗝𝗮𝗵𝗿𝗲𝘀𝘁𝗮𝗴𝘂𝗻𝗴 𝗱𝗲𝗿 𝗗𝗚𝗣𝗟 Ein großes Dankeschön für die großartige Organisation der diesjährigen Jahrestagung vom 02. - 05. Oktober in Freiburg. Das Interesse an iMS - dem Vorreiter in der endovenösen Lasertherapie mit 1940nm - ist weiterhin hoch. Wir freuen uns auf ein Wiedersehen 2025 in Salzburg!

𝗘𝘅𝗽𝗲𝗿𝗶𝗲𝗻𝗰𝗲𝗱 𝗽𝗵𝗹𝗲𝗯𝗼𝗹𝗼𝗴𝗶𝘀𝘁𝘀 𝗿𝗲𝗹𝘆 𝗼𝗻 𝘀𝗶𝗺𝗟𝗮® 𝟲 𝗲𝘃𝗲𝗻 𝗳𝗼𝗿 𝗹𝗮𝗿𝗴𝗲 𝗱𝗶𝗮𝗺𝗲𝘁𝗲𝗿𝘀 𝖳𝗈 𝖾𝗇𝗌𝗎𝗋𝖾 𝗈𝗉𝗍𝗂𝗆𝖺𝗅 𝗉𝖺𝗍𝗂𝖾𝗇𝗍 𝖼𝖺𝗋𝖾, 𝗂𝗍 𝗂𝗌 𝗂𝗆𝗉𝗈𝗋𝗍𝖺𝗇𝗍 𝗍𝗈 𝗌𝗍𝖺𝗒 𝗎𝗉 𝗍𝗈 𝖽𝖺𝗍𝖾. 𝖨𝗇 𝖺𝖽𝖽𝗂𝗍𝗂𝗈𝗇 𝗍𝗈 𝖼𝗈𝗇𝗍𝗂𝗇𝗎𝗈𝗎𝗌 𝗅𝖾𝖺𝗋𝗇𝗂𝗇𝗀, 𝗍𝗁𝖾 𝗅𝖺𝗍𝖾𝗌𝗍 𝗍𝖾𝖼𝗁𝗇𝗈𝗅𝗈𝗀𝗒 𝖽𝗈𝖾𝗌 𝖺𝗅𝗌𝗈 𝗉𝗅𝖺𝗒 𝖺 𝗆𝖺𝗃𝗈𝗋 𝗋𝗈𝗅𝖾. 𝖣𝗋. 𝖱𝖾𝗂𝖼𝗁𝖾𝗇𝖻𝖺𝖼𝗁 𝗂𝗌 𝖺𝗇 𝖾𝗑𝗉𝖾𝗋𝗂𝖾𝗇𝖼𝖾𝖽 𝗎𝗌𝖾𝗋 𝗈𝖿𝖿𝖾𝗋𝗂𝗇𝗀 𝖺 𝗆𝗈𝖽𝖾𝗋𝗇 𝖺𝗇𝖽 𝗉𝖺𝗍𝗂𝖾𝗇𝗍-𝗈𝗋𝗂𝖾𝗇𝗍𝖾𝖽 𝗏𝖺𝗋𝗂𝖼𝗈𝗌𝖾 𝗏𝖾𝗂𝗇 𝗍𝗋𝖾𝖺𝗍𝗆𝖾𝗇𝗍 𝗐𝗂𝗍𝗁 𝗂𝖬𝖲: "𝙏𝙝𝙚 𝙨𝙞𝙢𝙇𝙖 6 𝙞𝙣 𝙘𝙤𝙢𝙗𝙞𝙣𝙖𝙩𝙞𝙤𝙣 𝙬𝙞𝙩𝙝 𝙧𝙖𝙙𝙞𝙖𝙡𝙡𝙮 𝙚𝙢𝙞𝙩𝙩𝙞𝙣𝙜 𝙛𝙞𝙗𝙚𝙧𝙨 𝙖𝙡𝙡𝙤𝙬𝙨 𝙖 𝙛𝙡𝙪𝙨𝙝 𝙘𝙡𝙤𝙨𝙪𝙧𝙚 𝙤𝙛 𝙚𝙥𝙞𝙛𝙖𝙘𝙞𝙖𝙡 𝙫𝙚𝙞𝙣𝙨 𝙤𝙛 𝙖𝙣𝙮 𝙙𝙞𝙖𝙢𝙚𝙩𝙚𝙧 𝙚𝙫𝙚𝙣 𝙚𝙭𝙖𝙘𝙩𝙡𝙮 𝙖𝙩 𝙩𝙝𝙚 𝙟𝙪𝙣𝙘𝙩𝙞𝙤𝙣 𝙩𝙤 𝙩𝙝𝙚 𝙙𝙚𝙚𝙥 𝙫𝙚𝙞𝙣. 𝙄 𝙝𝙖𝙫𝙚 𝙗𝙚𝙚𝙣 𝙙𝙤𝙞𝙣𝙜 𝙩𝙝𝙞𝙨 𝙘𝙤𝙨𝙨𝙚𝙘𝙩𝙤𝙢𝙮-𝙡𝙞𝙠𝙚 𝙥𝙧𝙤𝙘𝙚𝙙𝙪𝙧𝙚 𝙨𝙪𝙘𝙘𝙚𝙨𝙨𝙛𝙪𝙡𝙡𝙮 𝙛𝙤𝙧 𝙢𝙖𝙣𝙮 𝙮𝙚𝙖𝙧𝙨 𝙬𝙞𝙩𝙝𝙤𝙪𝙩 𝙖𝙣𝙮 𝙨𝙞𝙙𝙚 𝙚𝙛𝙛𝙚𝙘𝙩𝙨." 𝖯𝖣 𝖣𝗋. 𝖥𝗋𝗂𝖾𝖽𝗋𝗂𝖼𝗁 𝖱𝖾𝗂𝖼𝗁𝖾𝗇𝖻𝖺𝖼𝗁 𝖲𝗉𝖾𝖼𝗂𝖺𝗅𝗂𝗌𝗍 𝖿𝗈𝗋 𝗏𝖺𝗌𝖼𝗎𝗅𝖺𝗋-/ 𝗌𝗎𝗋𝗀𝖾𝗋𝗒 𝖭𝗂𝖾𝖽𝖾𝗋𝗇𝖽𝗈𝗋𝖿, 𝖠𝗎𝗌𝗍𝗋𝗂𝖺

iMS auf der Jahrestagung der DGG 2024 Wie die Jahre zuvor sind wir auch dieses Jahr wieder auf der DGG mit einem Stand vertreten. Fragen sie uns, wenn sie sich für die minimalinvasive, endovenösen Behandlung mit 1940nm Laser interessieren. Wir freuen uns auf Sie!

Wir sind dabei! Vom 02.10. - 05.10. findet der Jahreskongress der Deutschen Gesellschaft für Phlebologie und Lymphologie (DGPL) im Konzerthaus in Freiburg statt. Das zentrale Thema ist "Wissenschaft und Praxis". Wir sind gespannt und freuen uns auf ein Wiedersehen sowie auf interessante Vorträge und Diskussionen.

iMS wishes everyone nice and relaxing summer holidays! Whether you've already had your vacation or are still looking forward to it, we hope you having a wonderful summer and a great time! @iMS we are still at your disposal...

𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫 𝐭𝐡𝐞 𝐏𝐨𝐰𝐞𝐫 𝐨𝐟 𝐭𝐡𝐞 𝐬𝐢𝐦𝐋𝐚® 𝟔 Our aim is to set new standards in varicose vein treatment. The patented wavelength of 1940 nm allows for effective and gentle treatment, resulting in a lower rate of negative side effects and the potential for a shorter recovery time. As a young company, we are still right at the beginning... Join us on our journey and stay excited about what's coming next. #iMSMedical #MedicalLaserRevolution #VaricoseVeinTreatment #InnovativeTechnology #PatientCare #MedicalInnovations

𝐄𝐕𝐋𝐀 𝐛𝐞𝐭𝐭𝐞𝐫 𝐭𝐡𝐚𝐧 𝐑𝐅𝐀? As a manufacturer of laser devices, we tend to be biased in answering this question. If we just reflect the feedback we have received from users knowing both systems, the answer is mostly "It depends." The greatest asset for Radiofrequency Ablation (RFA) systems is their simplicity in use combined with very good results. When it comes to the procedure itself, in real life, there don’t seem to be differences in procedure time and efficacy between RFA and EVLA. However, the feedback arguments for EndoVenous Laser Ablation (EVLA) that we regularly hear are: 1️⃣ Greater flexibility in use, especially with 1940nm, because of the lower energy input 2️⃣ Larger treatment scope (short segments; veins close to the skin, perforators...) 3️⃣ More flexible fibers and a much lower entry profile of up to 16G instead of a 6F/7F introducer These may not be all the points that play a role in the decision-making process... What’s your experience? #MedicalDevices #LaserTherapy #EndoVenousLaserAblation #RadiofrequencyAblation